After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, CRSP falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of CRISPR Therapeutics AG is $3.62B. A total of 4.72 million shares were traded on the day, compared to an average of 2.05M shares.
In the most recent transaction, Patel Naimish sold 3,932 shares of CRSP for 35.94 per share on May 29 ’25. After the transaction, the Chief Medical Officer now owns 6,068 company shares. In a previous transaction on Mar 21 ’25, Kulkarni Samarth sold 10,031 shares at 41.23 per share. CRSP shares that Chief Executive Officer owns now total 195,085.
Among the insiders who sold shares, Bruno Julianne disposed of 1,714 shares on Mar 21 ’25 at a per-share price of $41.23. This resulted in the Chief Operating Officer holding 10,544 shares of CRSP after the transaction. In another insider transaction, Prasad Raju sold 2,197 shares at $41.23 per share on Mar 21 ’25. Company shares held by the Chief Financial Officer now total 16,767.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRSP has a high of $67.88 and a low of $30.04.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $21.18, while its Total Shareholder’s Equity was $2.40B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRSP is Buy with a score of 4.11.